09.07.2019 Views

Diagnostic Ultrasound - Abdomen and Pelvis

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Adrenal Adenoma<br />

TERMINOLOGY<br />

Synonyms<br />

• Adrenocortical adenoma<br />

Definitions<br />

• Extremely common, benign tumor of adrenal cortex<br />

IMAGING<br />

General Features<br />

• Best diagnostic clue<br />

○ Small, well-circumscribed, homogeneous adrenal mass<br />

• Location<br />

○ Can be bilateral (10%)<br />

• Size<br />

○ Varies from 2-5 cm<br />

○ Smaller lesions are seen with Conn syndrome, usually < 2<br />

cm (20% < 1 cm)<br />

• Morphology<br />

○ Typically small, round, or oval, smoothly marginated, <strong>and</strong><br />

homogeneous<br />

○ Size is particularly important: Smaller adrenal lesions<br />

tend to be benign; > 4 cm more likely malignant<br />

– Size stability over 12 months supports benignity<br />

Ultrasonographic Findings<br />

• Nonspecific sonographic appearance<br />

• Well-circumscribed, solid, oval-shaped mass, typically < 3 cm<br />

• Usually homogeneous <strong>and</strong> hypoechoic<br />

○ Or slightly heterogeneous with mixed echogenicity<br />

• Atypically can appear more heterogeneous<br />

○ Possibly with hemorrhage/necrosis or calcification (rare)<br />

○ Necrosis is seldomseen in small adenoma<br />

CT Findings<br />

• Usually small (< 3 cm) <strong>and</strong> homogeneous<br />

• Smoothly marginated <strong>and</strong> well defined<br />

• Atypical features: Large size (> 3 cm), hemorrhage, cystic<br />

degeneration, calcification<br />

• NECT: CT characteristics depend on lipid content<br />

○ Lipid-rich adenomas (70-90%): Attenuation < 10 HU is<br />

characteristic <strong>and</strong> diagnostic<br />

○ Lipid-poor adenoma (10-30%): Variable attenuation from<br />

10-30 HU or higher, more nonspecific appearance<br />

○ May see gl<strong>and</strong>ular atrophy bilaterally in setting of<br />

Cushing syndrome<br />

• CECT: Avid enhancement with rapid de-enhancement<br />

○ Characteristic pattern of lesion washout when<br />

comparing enhancement on portal venous phase to<br />

attenuation at 10 min post injection: > 60% absolute<br />

percent washout<br />

– (Lesion attenuation on enhanced CT - lesion<br />

attenuation on delayed CT) / (lesion attenuation on<br />

enhanced CT - lesion attenuation on unenhanced CT) x<br />

100%<br />

– <strong>Diagnostic</strong> for adenoma<br />

– Independent of lipid content<br />

MR Findings<br />

• T1WI: Chemical shift MR can confirm presence of<br />

intracellular lipid<br />

○ Shows signal dropout on out-of-phase imaging<br />

– Compare lesion to spleen or muscle (SI of liver may be<br />

affected by lipid deposition)<br />

○ <strong>Diagnostic</strong> for adrenal adenomas containing lipid<br />

• T1WI C+: No established dynamic enhancement<br />

characteristics for MR<br />

Nuclear Medicine Findings<br />

• PET/CT<br />

○ No increased uptake of FDG<br />

○ Useful in differentiating from malignant lesions (↑<br />

uptake)<br />

Angiographic Findings<br />

• Adrenal venography: Adrenal vein sampling in setting of<br />

Conn syndrome<br />

○ Can distinguish unilateral vs. bilateral aldosterone<br />

secretion<br />

○ Higher aldosterone:cortisol ratio than peripheral sample<br />

= abnormal<br />

Imaging Recommendations<br />

• Best imaging tool<br />

○ NECT <strong>and</strong> CECT or MR<br />

• Protocol advice<br />

○ Full adrenal mass CT protocol should include NECT <strong>and</strong><br />

CECT (with 10 min delayed phase)<br />

– Check attenuation on NECT before contrast<br />

administration to eliminate unnecessary imaging<br />

– Use thin sections (3 mm) to better assess small lesions<br />

○ Chemical shift MR can also be used to characterize<br />

indeterminate adrenal nodules with attenuation of 10-<br />

30 HU<br />

○ CECT with 10 min delayed-phase imaging should be used<br />

to characterize indeterminate adrenal nodules with CT<br />

attenuation > 30 HU<br />

• Recommendations for evaluating nonspecific incidental<br />

adrenal nodules (ACR)<br />

○ ≤ 1 cm can be ignored<br />

○ 1-4 cm needs further evaluation or follow-up to establish<br />

stability<br />

○ ≥ 4 cm should undergo biopsy or PET<br />

DIFFERENTIAL DIAGNOSIS<br />

Adrenal Metastases<br />

• Unilateral or bilateral; more often hypoechoic than<br />

echogenic<br />

• ± necrosis or hemorrhage<br />

• Usually known to have malignancy elsewhere, although<br />

adenoma is still more common even in setting of known<br />

cancer<br />

• NECT: Metastases can mimic lipid-poor adenoma<br />

• CECT: Shows prolonged washout pattern, < 60% on 10 min<br />

delayed phase<br />

Adrenal Lymphoma<br />

• Unilateral or bilateral masses<br />

• Usually secondary spread to adrenal with evidence of<br />

lymphoma elsewhere<br />

• Unilateral primary lymphoma (non-Hodgkin) rare<br />

Diagnoses: Adrenal Gl<strong>and</strong><br />

593

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!